0001104659-24-083099.txt : 20240726
0001104659-24-083099.hdr.sgml : 20240726
20240726184044
ACCESSION NUMBER: 0001104659-24-083099
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240724
FILED AS OF DATE: 20240726
DATE AS OF CHANGE: 20240726
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: RAINES MERILEE
CENTRAL INDEX KEY: 0001023869
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36554
FILM NUMBER: 241148439
MAIL ADDRESS:
STREET 1: IDEXX LABORATORIES, INC.
STREET 2: ONE IDEXX DRIVE
CITY: WESTBROOK
STATE: ME
ZIP: 04092
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OCULAR THERAPEUTIX, INC
CENTRAL INDEX KEY: 0001393434
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
BUSINESS PHONE: 781-357-4000
MAIL ADDRESS:
STREET 1: 15 CROSBY DRIVE
CITY: BEDFORD
STATE: MA
ZIP: 01730
FORMER COMPANY:
FORMER CONFORMED NAME: I-THERAPEUTIX INC
DATE OF NAME CHANGE: 20070315
4
1
tm2420266-4_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-07-24
0
0001393434
OCULAR THERAPEUTIX, INC
OCUL
0001023869
RAINES MERILEE
C/O OCULAR THERAPEUTIX, INC.
15 CROSBY DRIVE
BEDFORD
MA
01730
1
0
0
0
0
Common Stock
2024-07-24
4
A
0
12000
0
A
32933
D
Stock Option (Right to Buy)
7.91
2024-07-24
4
A
0
36000
0
A
2034-07-23
Common Stock
36000
36000
D
On July 24, 2024, the reporting person was granted restricted stock units ("RSUs") under the 2021 Stock Incentive Plan, as amended, of Ocular Therapeutix, Inc. (the "Company"). Each RSU represents a right to receive one share of the Company's common stock. Subject to the reporting person's continued service on the Company's board of directors, the RSUs will vest with respect to 100% of the shares underlying the RSUs on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
Subject to the reporting person's continued service on the Company's board of directors, the options will vest with respect to 100% of the shares underlying the options on the first anniversary of the grant date or, if earlier, immediately prior to the next annual meeting of stockholders occurring after the grant date.
/s/Donald Notman, Attorney-in-Fact for Merilee Raines
2024-07-26